Skip to main content

Table 3 Percent inhibition of WNV-reactive MAb binding with competitive ELISA using sera from WNV-infected chicken and WNV-vaccinated horse during period between infection and serum collection

From: West Nile virus: characterization and diagnostic applications of monoclonal antibodies

 

Days post-infection/vaccination

WNV VN titer

% Inhibition of MAb binding

   

3B2

3D6

4D3

1C3

2A8

4G9

Chicken

0

< 5

0

4.7 ± 2.1

4.7 ± 1.5

8 ± 2

7 ± 1.2

4.3 ± 1.5

 

7

10

56.7 ± 2.1

76.7 ± 2.1

43.3 ± 2.5

79 ± 4.6

75.7 ± 1.5

75 ± 3.5

 

15

20

77 ± 1

80.3 ± 2.1

78.7 ± 2.5

86.7 ± 1.2

87 ± 2.6

91.7 ± 1.5

 

24

40

81 ± 2.6

80 ± 1.7

83.7 ± 1.5

89.3 ± 1.2

89 ± 1

94.3 ± 0.6

 

42

160

92.7 ± 1.5

95.3 ± 0.6

91 ± 1

93.7 ± 1.2

95.7 ± 1.2

94.3 ± 1.5

Horse

0

< 5

28.7 ± 2.1

15.7 ± 2.1

47.3 ± 2.5

19 ± 1

23.7 ± 1.5

23.3 ± 2.5

 

15

< 5

71 ± 2

42.3 ± 1.2

73 ± 1

42.7 ± 0.6

44 ± 1

64.3 ± 1.5

 

21

10

81.7 ± 1.5

65 ± 1

74.7 ± 0.6

69.3 ± 3.5

65.7 ± 1.5

80.3 ± 2.1

 

28

20

88.7 ± 0.6

71.7 ± 1.5

85.7 ± 1.5

78.7 ± 1.2

77 ± 2

88.3 ± 0.6

 

31 (2°v)

80

95.7 ± 0.6

92.7 ± 1.5

91.3 ± 1.2

91.7 ± 1.5

93.3 ± 3.1

95 ± 1

  1. MAbs were tested in triplicate. All sera were diluted 5 fold.
  2. Values are mean ± standard deviations.